key: cord-0731714-2jdwexmf
authors: Shafi, Ahmed M. A.; Atieh, Abed Elfattah; Harky, Amer; Sheikh, Amir M.; Awad, Wael I.
title: Impact of COVID‐19 on cardiac surgical training: Our experience in the United Kingdom
date: 2020-06-19
journal: J Card Surg
DOI: 10.1111/jocs.14693
sha: 7da833eead78dac5f9a06184e75add03292dcdf2
doc_id: 731714
cord_uid: 2jdwexmf

The current evolving global pandemic caused by coronavirus disease‐2019 (COVID‐19) has dramatically impacted global health care systems, resulting in governments taking unprecedented measures to contain the spread of the infection, with adaptations by health care organizations. Research into understanding the pathophysiology behind this virus, to ascertain best medical management and treatment, has been accelerated to keep up with the rapidly evolving situation. There has been redeployment of medical and nursing staff to the frontlines and redistribution of health care resources. In addition, the cancellation of elective surgery and centralization of services to treat high‐risk surgical cases will all, undeniably, have an impact on current surgical training with possible future implications. We aim to explore the impact COVID‐19 is having on cardiac surgical training in the UK and what future implications this may have.

COVID-19. The acceptance that only consultants or senior members should operate on these higher risk patients have diminished surgical trainee opportunities significantly. The Joint Committee on Surgical Training (JCST) have announced rotations would be suspended as this may result in an additional burden on the health care system in the current climate. However, the JCST have consequently announced that those trainees who are in need of further time to complete their training will be warranted with additional time to do so following the current pandemic, in order that the integrity of surgical training is maintained.

The strain on health care resources, despite efforts to increase hospital and intensive care capacity, has led to the need for rationing of medical equipment and interventions. Subsequently, countries have canceled/curtained elective surgery and have centralized cardiothoracic services in an attempt to provide a service. [2] [3] [4] Based on current observed disease trends, cardiovascular specialists will play an active role in the care of patients with COVID-19. COVID-19 results in vascular inflammation, plaque instability and myocardial inflammation, 1 consequently patients that suffer from an acute coronary syndrome and subsequently develop COVID-19 have a poor prognosis. 11 In addition, COVID-19 poses an increased risk in patients undergoing cardiac surgery, who are already characterized by a proinflammatory state, in the postoperative period. As a result, a higher mortality may be associated with patients undergoing cardiac surgery and subsequently developing COVID-19. Italy reported a COVID-19related mortality of 12.8% and 20.2% in patients aged 70 to 79 and over 80s respectively, in which a large part of the cardiac surgical patient population fall. 12 The indication for cardiac surgery is often based on evidencebased medicine but now, the RCS advises that nonoperative management where possible and reasonable should be implemented.

In the current climate, the risk of delaying surgical care must be It is also inevitably that there will be a backlog of future elective work with further potentially negative effects on patient outcomes and training, particularly if these patients go on to require urgent/ emergency intervention as this pandemic continues. In addition, as a result of the lockdown measures and general anxiety, patients with progressive disease may delay their seeking medical care. Subsequently, these cases may carry higher surgical risk and ultimately be performed by consultants once again impacting training downstream.

Cardiac Surgery group has advised that only two of the seven (of which we are one) cardiac surgical centers in London will provide a cardiac surgical service. The reduced opportunity for trainees at these two centers is shadowed by the fact that trainees at the remaining five centres will not have any opportunity for training in cardiac surgery, with this model ultimately extending across the rest of the UK. In light of the impact on training, the JCST in the UK has stated that the Annual Review of Competency Progression (process by which doctors in training are reviewed each year to ensure that they are offering safe, quality patient care, and to assess their progression against standards set down in the curriculum for their training program) panels will continue to be able to review trainees' portfolios online, with the aim of ensuring that trainees were engaged in training and progress towards curriculum requirements had been on track before the COVID-19 outbreak. Requirements that have not been met due to the current circumstances would not be held against the trainee, with an opportunity offered to complete them, once the current situation is over. The JCST also recommends that trainees, who have/will not been able to sit the specialty exam before their provisional certification dates, should have their training extended to allow them to sit it at the next available opportunity. Those trainees who have already passed this exam and met all requirements should be allowed, to be accredited even if certain courses have not been completed on condition that the trainees' portfolio shows they will be safe to practice. The integrity of surgical training across all specialities and the sustainability of the workforce should be maintained as surgical trainees find themselves with the task of balancing service and education. In addition, reorganization of workflow and adaptation of educational milestones can help reduce the disruption to surgical training. The effects of COVID-19 on training can also potentially be mitigated by means of E-Learning (include viewing online lectures, web seminars (webinars) and podcasts) and simulation-based e-learning delivered in a variety of formats, including virtual patients, computer-based physiology simulators or advanced surgical simulators that allow practice of surgical procedures such as valve replacement or coronary artery bypass.

The COVID-19 pandemic is an evolving global health care crisis; the impact in the current climate is evident, however there is uncertainty as to what the true cost will be. Many questions are being raised, with enormous efforts from the scientific community and with a second wave of COVID-19 expected by many health experts to be worse. The extent to which training and the process of accreditation will be affected remains uncertain, together with the uncertainty of the clinical state of the patients on elective lists that have been delayed. For now, all that is certain is that it is not "business as usual."

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

COVID-19 experience in Bergamo, Italy

The COVID-19 outbreak and its impact on hospitals in Italy: the model of cardiac surgery

Cardiac surgery in Canada during the COVID-19 pandemic: a guidance statement from the Canadian Society of Cardiac Surgeons

Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis

Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China

Influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years of autopsies in 34,892 subjects

Seasonal influenza infections and cardiovascular disease mortality

Acute myocardial infarction after laboratory-confirmed influenza infection

Risk of myocardial infarction and stroke after acute infection or vaccination

COVID-19 and the cardiovascular system

Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy